Le Lézard
Classified in: Health, Covid-19 virus
Subject: CFG

Update #5: Statement from the Chief Public Health Officer on the release of selected individuals from quarantine for the 2019 novel coronavirus

OTTAWA, Feb. 23, 2020 /CNW/ - Further to my previous statements, as Chief Public Health Officer, I have assessed individuals in quarantine at the NAV CENTRE pursuant to an Emergency Order under the Quarantine Act and determined that they do not pose a risk of significant harm to public health.

I have authorized the release of six Canadian Armed Forces (CAF) medical staff and one Government of Canada employee who accompanied the returning travellers on the third Canada-chartered flight from Japan to CFB Trenton to the NAV CENTRE in Cornwall, Ontario. In my assessment, I took into account the fact that they followed appropriate infection prevention and control protocols (including the use of personal protective equipment), and that they did not have unprotected contact with passengers or persons at risk of having the novel coronavirus. As a result of this assessment, I have determined that their continued quarantine is not required.

SOURCE Public Health Agency of Canada

These press releases may also interest you

at 13:01
Metabolomic Technologies Inc. (MTI) is excited to announce the national expansion of its proprietary and innovative test, PolypDxtm. This non-invasive, convenient urine test is a major breakthrough to detect adenomatous polyps and help prevent colon...

at 13:00
The "Anaerobic Digestion Deployment in the UK" report has been added to ResearchAndMarkets.com's offering. This 2020 edition of the annual report provides a comprehensive regional breakdown of sector development in Scotland, Wales, Northern Ireland,...

at 13:00
The Parenteral Drug Association (PDA) today announced the availability of a new website for the PDA Foundation, a 501(c)(3) nonprofit founded in 1997 to help support PDA and other industry activities. This new website makes it easier for industry...

at 12:48
- Curesponse is a cancer precision medicine company whose platform, cResponse, accurately and quickly predicts a patient's response to cancer treatment. - The company has raised $6M from investors including NCL Technology Ventures (UK) and aMoon...

at 12:25
Compassion & Choices today announced a historic collaboration with the Ventanillas de Salud (Windows of Health) network to launch a bilingual educational campaign during the COVID-19 crisis to inform U.S.-based Mexican immigrants about their full...

at 12:17
We know Canadians living with disabilities are facing significant challenges during this difficult time, with some experiencing job insecurity and others seeing increased costs for personal support workers, medication, and medical supplies. As we...

News published on 23 february 2020 at 21:00 and distributed by: